Anselm, Anjali <br/><br/>
Prolonged basiliximab use as an alternative to calcineurin inhibition to allow renal recovery late after heart transplantation.  [electronic resource] 

 -  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation  Sep 2008 
 - 1043-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1557-3117 
<br/><br/><label>Standard No.: </label>10.1016/j.healun.2008.04.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--etiology<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antigens, CD--blood<br/>Basiliximab<br/>Calcineurin--adverse effects<br/>Cardiomyopathies--surgery<br/>Drug Administration Schedule<br/>Female<br/>Graft Rejection--prevention & control<br/>Graft Survival--drug effects<br/>Heart Arrest--etiology<br/>Heart Transplantation--immunology<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Interleukin-2 Receptor alpha Subunit--blood<br/>Kidney--drug effects<br/>Postoperative Complications--diagnosis<br/>Recombinant Fusion Proteins--therapeutic use<br/>Treatment Outcome<br/>Ventricular Dysfunction, Right--diagnosis<br/>Waiting Lists